Vanguard Group Inc Organogenesis Holdings Inc. Call Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORGO
# of Institutions
125Shares Held
63.6MCall Options Held
0Put Options Held
500-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$46.2 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$43.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$18.8 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$11.4 Million0.03% of portfolio
-
Assenagon Asset Management S.A.2.95MShares$10.9 Million0.02% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $484M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...